Cite
MLA Citation
Peter G Kremsner et al.. “Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial.” Lancet infectious diseases, vol. 22, no. 3, 2022, pp. 329–340. http://access.bl.uk/ark:/81055/vdc_100152300146.0x000014